Stem Cell Treatment for -

Sargramostim Treatment for Alzheimer's Disease

At Stem Cell Treatment Institute advanced procedures are performed at some of the most scientifically advanced hospitals in the world.

GM-CSF Sargramostim Leukine Treatment

GM-CSF Therapy for Alhiemer's Disease is focused on affecting physical changes in the brain that can improve a patient's quality of life.


Alzheimer's patients can be treated by lumbar puncture (injecting the cells into the cerebrospinal fluid), IV, or other techniques like GM-CSF short for hematopoietic growth factor granulocyte-macrophage colony-stimulating factor.


Sargramostim is a synthetic form of the hematopoietic growth factor granulocyte-macrophage colony-stimulating factor (GM-CSF). It is a 127 amino acid glycoprotein produced by recombinant DNA technology in yeast. Sargramostim stimulates the innate immune system. It is FDA-approved for regenerating neutrophils, monocytes, and macrophages after bone marrow transplants and in conjunction with treatment for several types of leukemia. Sargramostim is also used for treating neutropenia, a condition of dangerously low white-blood-cell counts. Sargramostim is not to be confused with filgrastim, a recombinant form of the related granulocyte colony-stimulating factor (G-CSF).


G-CSF seems to promote improved cognition with persistent effect.


Back in 2012, it was shown in this study (Granulocyte Macrophage Colony Stimulating Factor Treatment is Associated with Improved Cognition in Cancer Patients https://www.omicsgroup.org/journals/granulocyte-macrophage-colony-stimulating-factor-treatment-is-associated-with-improved-cognition-in-cancer-patients-2168-975X.1000101.php) that its effects may occur over a protracted period of 12 months, yet appear to be clinically significant in magnitude. This same study demonstrated that GMCSF (GM-CSF, granulocyte macrophage colony stimulating factor) both enhanced and accelerated the onset of clinical improvement. GMCSF is FDA-approved as Leukine (sargramostim) for post cemo cancer patients.


Treatment using autologous (patient source) or donor cells (placenta) are also available.


If Autologous Bone Marrow is used bone marrow is collected from the patient's iliac crest (hip bone) using thin-needle puncture under local anesthesia. Once the bone marrow collection is complete, patients may return to their suite or hotel and go about normal activities.


The stem cells are then processed in a state-of-the-art laboratory. In the lab, both the quantity and quality of the stem cells are measured. The stem cells are then implanted back into the patient by lumbar puncture or IV.

Stem Cell Specialist

Stem Cell Specialist Dr. Lopez works with a team of highly trained and experienced specialists including neurologists, neurosurgeons, oncologists, hematologists, ophthalmologists, and pediatricians.

We offer Stem Cell treatments with enhanced or manipulated stem cells. These expanded and mobilized stem cells have been found to provide better results than non-manipulated stem cell applications.


Manipulation or amplification of the stem cells is done in the lab, where care is taken to retain the cell properties. These expanded and mobilized cells provide superior results and cell recovery has been found to occur twice as fast as with non-manipulated stem cell applications.